severe combined immunodeficiency syndrome (SCID)

New PCR-based approaches simplify molecular testing for health issues in infants, making diagnostic approaches simpler and more accessible across laboratories.

Scientists hoping to treat immunodeficiencies using gene therapy have found a way to edit stem cells in mice without disrupting gene regulation.

Four dozen children with severe combined immunodeficiency (SCID) who received a corrective gene carried by a virus have working immune systems two to three years later, according to three independent clinical trials.